International developed-market exposure has become a focal point for investors seeking diversification beyond U.S. equities, and these two ETFs illustrate very different ways to build that allocation. IDMO pursues a concentrated, momentum-driven approach targeting stocks with the strongest recent price trends, while IEFA offers broad, low-cost ownership of developed markets outside North America. They do not compete directly as identical strategies; rather, they represent alternative answers to the same investor question — how to access international equities. Comparing their structure, cost, and risk profiles helps clarify which tool better suits a given portfolio and which one the market's current dynamics favor. I also checked sector overlaps using Tickeron’s AI Trend Prediction Engine to get a clearer sense of how these holdings might behave going forward.
IDMO is a passively managed ETF that tracks the S&P Momentum Developed ex-U.S. & South Korea LargeMidCap Index, a rules-based benchmark that selects stocks from the developed international universe exhibiting the highest momentum scores. The fund holds roughly 166 securities and carries a 0.25% expense ratio. Its momentum methodology produces notable concentration: financials account for more than 40% of the portfolio, with industrials as a significant secondary allocation. Top holdings include HSBC Holdings, Toronto-Dominion Bank, Banco Santander, Siemens Energy, Banco Bilbao Vizcaya Argentaria, Advantest, and Rolls-Royce. Geographically, Japan and Canada are the largest country weights, followed by the Netherlands, Spain, and the United Kingdom. The index rebalances periodically to refresh momentum rankings, meaning sector and country weights can shift as trends rotate.
IEFA is a passively managed ETF that seeks to track the MSCI EAFE Investable Market Index (IMI), a broad benchmark covering large-, mid-, and small-capitalization equities across developed markets in Europe, Australasia, and the Far East. The fund holds approximately 2,600 securities and charges an ultra-low 0.07% expense ratio. Its market-cap-weighted structure produces a balanced sector profile: financials lead at roughly 24%, followed by industrials near 19%, technology around 11%, and healthcare near 10%. Top holdings include ASML, HSBC Holdings, Roche, Shell, Novartis, Mitsubishi UFJ Financial Group, AstraZeneca, Nestlé, Siemens, and BHP Group. Japan is the largest country exposure, followed by the United Kingdom, Germany, France, and Switzerland. Unlike IDMO, IEFA excludes both the U.S. and Canada, making it a pure "rest of the developed world" allocation. From what I see in the data, this breadth stands out as a core strength.
Both funds operate within the same broad international developed-market landscape, shaped by several durable catalysts. A historically strong U.S. dollar and elevated domestic valuations have pushed many investors to reconsider overseas equities. Meanwhile, Japan's corporate-governance reforms and shareholder-return initiatives have drawn capital to Japanese large caps, which feature prominently in both portfolios. The European banking sector — a major weight in IDMO — has benefited from higher interest rates, which tend to expand net interest income. Broader risks include slowing euro-area growth, currency volatility, and geopolitical uncertainty, all of which affect the relative momentum and valuation of international equities. I ran a quick comparison of these themes through Tickeron’s AI Pattern Search Engine to see how recent price action aligned with the fundamentals.
Over recent market cycles, IDMO's momentum tilt has amplified exposure to whatever sectors were trending, most notably financials, which rallied alongside rising global rates. This concentration has supported strong relative returns during trending markets but also introduces higher volatility and drawdown risk when leadership rotates. IEFA, by contrast, has delivered steadier, index-like performance driven by its diversified weightings across banks, industrial exporters, semiconductor equipment makers, and healthcare firms. Its broader exposure to technology and healthcare has provided ballast when financials cooled, while IDMO's narrower footprint leaves it more sensitive to any single sector's fortunes. In liquidity terms, IEFA is the larger and more heavily traded vehicle, typically offering tighter bid-ask spreads than IDMO. One thing that stands out is how these differences play out in real portfolios.
I often rely on Tickeron’s AI Screener when comparing ETFs like these. It lets me filter across technical patterns, fundamentals, and AI signals to quickly surface how holdings stack up against peers. The tool has helped me refine my own research process by highlighting diversification metrics and cost differences that might otherwise take longer to uncover manually. It is a practical addition to the workflow for anyone evaluating international strategies.
On balance, Tickeron's AI would likely favor IEFA over IDMO in the current environment. The decisive factors are structural: IEFA offers a materially lower expense ratio (0.07% versus 0.25%), far broader diversification across roughly 2,600 holdings, and a more balanced sector footprint that reduces single-sector concentration risk. While IDMO's momentum methodology can capture powerful trends in favored sectors such as financials, that same concentration increases downside sensitivity when leadership rotates. Given IEFA's combination of cost efficiency, diversification profile, liquidity, and trend consistency, the AI verdict tilts toward IEFA for investors seeking resilient, broad-based international developed-market exposure. This assessment is probabilistic and reflects observable fund characteristics rather than a personal investment recommendation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The Moving Average Convergence Divergence (MACD) for IEFA turned positive on November 09, 2026. Looking at past instances where IEFA's MACD turned positive, the stock continued to rise in 42 of 45 cases over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on IEFA as a result. In 63 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
Following a +0.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where IEFA advanced for three days, in 264 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 59 cases where IEFA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.
IEFA moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IEFA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
IEFA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IEFA entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows